Prognostic Value of Pretreatment Neutrophil-to-Lymphocyte Ratio in HER2-Positive Metastatic Breast Cancer

Prognostic Value of Pretreatment Neutrophil-to-Lymphocyte Ratio in HER2-Positive Metastatic Breast Cancer

This study aimed to examine the prognostic value of the neutrophil-to-lymphocyte ratio (NLR) and other clinicopathological features in HER2+ MBC patients who received first-line anti-HER2 therapy. A total of 129 patients were assigned to NLR-low and NLR-high groups based on a cutoff value of 3.0 at...

Full description

Bibliographic Details
Main Authors: Bin Shao, Xiaoran Liu, Huiping Li, Guohong Song, Lijun Di, Hanfang Jiang, Ying Yan, Ruyan Zhang, Ran Ran, Jiayang Zhang, Yaxin Liu, Huan Wang, Jing Wang
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Current Oncology
Subjects:
neutrophil-to-lymphocyte ratio
HER2 positive
metastatic breast cancer
prognosis
anti-HER2 treatment
Online Access:https://www.mdpi.com/1718-7729/29/9/483

Similar Items

Similar Items